Back to top

medical-devices: Archive

Debanjana Dey

Hims & Hers Stock Plunges 32.1% in Three Months: What's Next?

HIMS is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are likely to hurt its performance.

ABTNegative Net Change TDOCNegative Net Change HIMSPositive Net Change

Zacks Equity Research

BD Stock Falls After Acquisition of Edwards' Critical Care Group

BDX expands its smart care portfolio by acquiring Edwards Lifesciences' Critical Care group, now BD Advanced Patient Monitoring, strengthening AI-driven health solutions.

BDXPositive Net Change DGXPositive Net Change UHSPositive Net Change EWPositive Net Change

Zacks Equity Research

Should You Continue to Retain ABT Stock in Your Portfolio Now?

Abbott's robust strength in Core Diagnostics and EPD businesses should continue to benefit in the upcoming quarters.

ABTNegative Net Change BSXPositive Net Change VCYTNegative Net Change TMDXNegative Net Change

Zacks Equity Research

Butterfly Network's Stock Surges on iQ3 Device Launch in Europe

Shares of BFLY gain almost 27% following the announcement of the launch of its latest handheld ultrasound device, Butterfly iQ3, in Europe.

BSXPositive Net Change UHSPositive Net Change APYXNegative Net Change BFLYNegative Net Change

Zacks Equity Research

HealthEquity Stock Rises on Q2 Earnings and Revenue Beat

HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.

DGXPositive Net Change UHSPositive Net Change ABMNegative Net Change HQYNegative Net Change

Zacks Equity Research

AngioDynamics Stock Falls Despite CE Mark for Auryon System

ANGO's Auryon Atherectomy System earns CE Mark, which expands its European market reach and enhances PAD treatment with advanced laser technology.

ANGONegative Net Change DGXPositive Net Change UHSPositive Net Change ABMNegative Net Change

Urmimala Biswas

Buy These 3 Medical Info Systems Stocks to Capitalize on GenAI Boom

Zacks Medical Info Systems industry stocks like Inspire Medical Systems, Clover Health Investments and CareCloud are expected to gain from the GenAI wave.

INSPPositive Net Change CLOVNegative Net Change CCLDPositive Net Change

Zacks Equity Research

Reasons to Retain Cardinal Health Stock in Your Portfolio Now

CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.

BSXPositive Net Change UHSPositive Net Change CAHPositive Net Change APYXNegative Net Change

Zacks Equity Research

Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump

EMBC's shares close higher following FDA clearance for its disposable patch pump for insulin delivery, expanding the target market with its availability for type 2 diabetes.

BSXPositive Net Change UHSPositive Net Change APYXNegative Net Change EMBCNegative Net Change

Zacks Equity Research

Should You Consider Retaining ZBH Stock in Your Portfolio Now?

Zimmer Biomet's robust efforts to expand the Knee business and a gradually stabilizing musculoskeletal market appear promising.

BSXPositive Net Change ZBHPositive Net Change VCYTNegative Net Change TMDXNegative Net Change

Zacks Equity Research

EW Stock Dips Following the Divestiture of Critical Care Wing

Edwards completes the sale of its Critical Care operations and announces a $1 billion share repurchase program.

BDXPositive Net Change EWPositive Net Change AXGNNegative Net Change EXASPositive Net Change

Zacks Equity Research

Should You Continue to Retain PODD Stock in Your Portfolio Now?

Insulet's Omnipod 5 is set to drive growth in the upcoming quarters. Meanwhile, the stock is facing challenges due to economic uncertainties.

BSXPositive Net Change PODDPositive Net Change VCYTNegative Net Change TMDXNegative Net Change

Shaun Pruitt

Top Medical Stocks to Hedge Against the September Effect

Often sought out for defensive protection amid heightened market volatility, medical stocks may be of interest to investors in September which has historically been the most challenging month for stocks.

LLYNegative Net Change DVANegative Net Change HCAPositive Net Change

Zacks Equity Research

Greenville Center to Boost CAH Stock's at-Home Solution Business

Cardinal Health announces the opening of its new distribution center in Greenville to support its at-Home Solutions business.

DGXPositive Net Change UHSPositive Net Change CAHPositive Net Change ABMNegative Net Change

Zacks Equity Research

Femasys Shares Rise on CE Mark & Canada Approval for FemVue MINI

FEMY's eco-friendly FemVue MINI receives CE Mark and Health Canada approval, advancing sustainable fallopian tube assessment technology in Europe and Canada.

DGXPositive Net Change UHSPositive Net Change ABMNegative Net Change FEMYPositive Net Change

Zacks Equity Research

Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now

QDEL's strong product portfolio raises optimism about the stock.

BSXPositive Net Change UHSPositive Net Change QDELNegative Net Change APYXNegative Net Change

Zacks Equity Research

EW Stock to Benefit From Favorable RHEIA Trial Data on TAVI

Edwards' first all-female TAVI Trial demonstrates favorable outcomes for women receiving Edwards valves.

EWPositive Net Change AXGNNegative Net Change EXASPositive Net Change SIBNNo Net Change

Zacks Equity Research

Delcath Systems Stock Gains on Positive CHEMOSAT Melanoma Data

DCTH's study of the CHEMOSAT Hepatic Delivery System shows that the device significantly boosts survival rates in uveal melanoma patients with liver metastases, outperforming systemic therapies.

DGXPositive Net Change UHSPositive Net Change ABMNegative Net Change DCTHNegative Net Change

Zacks Equity Research

DaVita Rallies 44% Year to Date: What's Driving the Stock?

DVA's shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.

DGXPositive Net Change UHSPositive Net Change DVANegative Net Change ABMNegative Net Change

Zacks Equity Research

Should You Consider Retaining Bruker Stock in Your Portfolio Now?

BRKR's robust growth potential across its major segments is encouraging. Yet, macro woes and competitive pressure can pose challenges.

BSXPositive Net Change BRKRPositive Net Change VCYTNegative Net Change TMDXNegative Net Change

Zacks Equity Research

QuidelOrtho Expands in Infectious Disease Testing With New FDA Nod

QDEL announces the FDA's clearance for its VITROS syphilis assay, which boosts the company's infectious disease testing portfolio.

DGXPositive Net Change UHSPositive Net Change ABMNegative Net Change QDELNegative Net Change